LaSalle Street Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

LaSalle Street Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$686K	Hold	9,412	–	–	0.8%	47
2019 Q2	$774K	Hold	9,412	–	–	0.91%	43
2019 Q1	$664K	Sell	9,412 -768	-8%	-$45.2K	0.78%	45
2018 Q4	$458K	Buy	10,180 +677	+7%	+$35.5K	0.66%	54
2018 Q3	$537K	Buy	9,503 +2,989	+46%	+$183K	0.63%	56
2018 Q2	$435K	Sell	6,514 -2,873	-31%	-$179K	0.43%	71
2018 Q1	$547K	Sell	9,387 -299	-3%	-$19K	0.43%	73
2017 Q4	$624K	Buy	9,686 +1,367	+16%	+$85K	0.43%	70
2017 Q3	$437K	Buy	8,319 +3,246	+64%	+$155K	0.32%	76
2017 Q2	$237K	Hold	5,073	–	–	0.19%	80
2017 Q1	$251K	Buy	+5,073	New	+$285K	0.21%	81
2016 Q3	–	Sell	-4,383	Closed	-$245K	–	90
2016 Q2	$245K	Buy	+4,383	New	+$213K	0.23%	71
2016 Q1	–	Sell	-4,574	Closed	-$206K	–	82
2015 Q4	$206K	Buy	+4,574	New	+$197K	0.2%	80

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

LaSalle Street Capital Management's ANIP Position: Q3 2019 in Review

LaSalle Street Capital Management held its ANI Pharmaceuticals (ANIP) position steady in Q3 2019 at 9,412 shares worth $686K. The position accounts for 0.8% of the portfolio, ranked #47.

LaSalle Street Capital Management first reported a position in ANIP in Q4 2015 and has held it in 13 quarters since. The position peaked at $774K in Q2 2019. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

LaSalle Street Capital Management held 9,412 shares of ANI Pharmaceuticals worth $686K as of Q3 2019.
LaSalle Street Capital Management left its ANI Pharmaceuticals share count unchanged in Q3 2019.
ANI Pharmaceuticals made up 0.8% of LaSalle Street Capital Management's portfolio in Q3 2019, its #47 holding.
LaSalle Street Capital Management first reported a position in ANI Pharmaceuticals in Q4 2015 and has held it in 13 quarters since.
LaSalle Street Capital Management's ANI Pharmaceuticals position peaked at $774K in Q2 2019.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on LaSalle Street Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.